BioNTech reports FDA clinical hold on Phase I/IIa trial of BNT165e
In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...
Contract Pharma11h
Mural Health, ICON Partner to Enhance Site Experience in Clinical Trials
Will use Mural Link’s functionality related to clinical trial participant support services, communication tools, and ...
U.S. FDA places clinical hold on BioNTech's malaria vaccine study
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Yale Daily News20h
Yale scientists design personalized cancer vaccine
A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...
Icon adopting Mural Health’s participant management and payments platform
Icon (ICLR) and Mural Health, a clinical trial technology company, announced a partnership to utilize Mural’s participant management and ...
York clinical trail site reports 'flying start'
A York clinical trail site reports it has got off to a flying start with nearly 1000 local patients wanting to take part ...